Plasma CD147 reflects histological features in patients with lupus nephritis

  • M Maeda-Hori
    Department of Nephrology, Nagoya University Graduate School of Medicine, Nagoya, Japan
  • T Kosugi
    Department of Nephrology, Nagoya University Graduate School of Medicine, Nagoya, Japan
  • H Kojima
    Department of Nephrology, Nagoya University Graduate School of Medicine, Nagoya, Japan
  • W Sato
    Department of Nephrology, Nagoya University Graduate School of Medicine, Nagoya, Japan
  • S Inaba
    Department of Nephrology, Nagoya University Graduate School of Medicine, Nagoya, Japan
  • K Maeda
    Department of Nephrology, Nagoya University Graduate School of Medicine, Nagoya, Japan
  • H Nagaya
    Department of Nephrology, Nagoya University Graduate School of Medicine, Nagoya, Japan
  • Y Sato
    Department of Nephrology, Nagoya University Graduate School of Medicine, Nagoya, Japan
  • T Ishimoto
    Department of Nephrology, Nagoya University Graduate School of Medicine, Nagoya, Japan
  • T Ozaki
    Department of Nephrology, Nagoya University Graduate School of Medicine, Nagoya, Japan
  • N Tsuboi
    Department of Nephrology, Nagoya University Graduate School of Medicine, Nagoya, Japan
  • Y Muro
    Department of Dermatology, Nagoya University Graduate School of Medicine, Nagoya, Japan
  • Y Yuzawa
    Department of Nephrology, Fujita Health University School of Medicine, Toyoake, Japan
  • E Imai
    Department of Nephrology, Nagoya University Graduate School of Medicine, Nagoya, Japan
  • RJ Johnson
    Department of Renal Diseases and Hypertension, University of Colorado Denver, Denver, CO, USA
  • S Matsuo
    Department of Nephrology, Nagoya University Graduate School of Medicine, Nagoya, Japan
  • K Kadomatsu
    Department of Biochemistry, Nagoya University Graduate School of Medicine, Nagoya, Japan
  • S Maruyama
    Department of Nephrology, Nagoya University Graduate School of Medicine, Nagoya, Japan

書誌事項

公開日
2014-01-28
権利情報
  • https://journals.sagepub.com/page/policies/text-and-data-mining-license
DOI
  • 10.1177/0961203314520840
公開者
SAGE Publications

この論文をさがす

説明

<jats:sec><jats:title>Objective</jats:title><jats:p> A glycosylated transmembrane protein, CD147, has been implicated in regulating lymphocyte responsiveness and leukocyte recruitment. As lupus nephritis (LN) often follows a relapsing-remitting disease course, accurate understanding of the disease activity would be extremely helpful in improving prognosis. Unfortunately, neither clinical nor serological data can accurately reflect the histological features of LN. The present study investigated whether CD147 can accurately predict pathological features of LN. </jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p> Plasma and spot urine samples were collected from 64 patients who underwent renal biopsy between 2008 and 2011. Disease activity for LN tissues was evaluated using the biopsy activity index, and compared to levels of biomarkers including CD147. </jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p> In LN tissues, CD147 induction was striking in injured glomeruli and infiltrating inflammatory cells, but not in damaged tubules representing atrophy. Plasma CD147 levels accurately reflected the histological disease activity. However, prediction using a single molecule would be quite difficult because of the complex pathogenesis of LN. The diagnostic accuracy of multiplex parameters indicated that the combination including plasma CD147 might yield excellent diagnostic abilities for guiding ideal LN therapy. </jats:p></jats:sec><jats:sec><jats:title>Conclusion</jats:title><jats:p> Plasma CD147 levels might offer useful insights into disease activity as a crucial biomarker in patients with LN. </jats:p></jats:sec>

収録刊行物

  • Lupus

    Lupus 23 (4), 342-352, 2014-01-28

    SAGE Publications

被引用文献 (10)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ